Free Trial

Curaleaf (OTCMKTS:CURLF) Shares Gap Up - Here's Why

Curaleaf logo with Medical background

Key Points

  • Curaleaf's stock price increased from $2.85 to $3.00 before the market opened, with a total volume of 199,138 shares traded.
  • The stock was upgraded from a "hold" to a "moderate buy" rating by Cormark, and currently has an average rating of "Strong Buy" from analysts.
  • Despite beating earnings estimates with a reported loss of ($0.06) EPS, Curaleaf has a negative net margin of 18.08% and continues to forecast further losses for the current year.
  • MarketBeat previews the top five stocks to own by October 1st.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $2.85, but opened at $3.00. Curaleaf shares last traded at $3.00, with a volume of 199,138 shares traded.

Wall Street Analyst Weigh In

Separately, Cormark upgraded Curaleaf from a "hold" rating to a "moderate buy" rating in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Strong Buy".

View Our Latest Analysis on Curaleaf

Curaleaf Price Performance

The business's 50 day simple moving average is $1.91 and its 200-day simple moving average is $1.26. The company has a quick ratio of 0.70, a current ratio of 1.47 and a debt-to-equity ratio of 1.00. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of -9.25 and a beta of 0.75.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. On average, research analysts forecast that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.